MCM
M28 Capital Management Portfolio holdings
AUM
$58.6M
This Quarter Return
-19.14%
1 Year Return
+32.71%
3 Year Return
+247.5%
5 Year Return
–
10 Year Return
–
AUM
$73M
AUM Growth
+$73M
(-28%)
Cap. Flow
-$2.44M
Cap. Flow
% of AUM
-3.34%
Top 10 Holdings %
Top 10 Hldgs %
99.28%
Holding
11
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$2.44M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Wave Life Sciences
WVE
$1.53B
| $45.8M | 62.72% | 5,664,548 | – | – |
|
2
TG Therapeutics
TGTX
$4.65B
| $6.37M | 8.73% | 161,600 | – | – |
|
3
Invivyd
IVVD
$204M
| $5.6M | 7.67% | 9,248,250 | – | – |
|
4
BridgeBio Pharma
BBIO
$9.89B
| $4.19M | 5.74% | 121,200 | – | – |
|
5
Rocket Pharmaceuticals
RCKT
$354M
| $2.57M | 3.53% | 385,680 | – | – |
|
|
SWTX
6
DELISTED
SpringWorks Therapeutics
SWTX
| $2.44M | 3.34% | 55,200 -55,200 | -50% | -$2.44M |
|
7
Fractyl Health
GUTS
$68.8M
| $2.21M | 3.03% | 1,856,117 | – | – |
|
8
ProQR Therapeutics
PRQR
$237M
| $1.36M | 1.86% | 1,019,498 | – | – |
|
9
Curis
CRIS
$20.9M
| $1.09M | 1.5% | 521,059 | – | – |
|
10
Arrowhead Research
ARWR
$3.05B
| $859K | 1.18% | 67,400 | – | – |
|
|
SLN
11
Silence Therapeutics
SLN
$227M
| $522K | 0.72% | 185,100 | – | – |
|